WST
West Pharmaceutical Services, Inc.$359.00+1.22% 1D· price as of Jun 30, 8:32 PM+63.93% over 1Y
Compare:WST
Mkt Cap
$25.4B
P/E
48.0×
Fwd P/E
37.6×
PEG
3.38
P/B
8.5×
P/S
7.9×
EV/EBITDA
28.6×
Beta
1.18
Div Yield
0.3%
Payout
11.5%
ROE
19.1%
Net Margin
16.8%
Short % Flt
3.3%
Inst. Own
103.9%
52-wk low $206.80$359.0052-wk high $359.66
+73.6% above low-0.2% from high
Seasonality — avg monthly return
Strongest Jul 5.4% · weakest Sep -5.8%Jan
-0.6
Feb
-2.4
Mar
+3.5
Apr
+0.2
May
-0.3
Jun
+4.7
Jul
+5.4
Aug
+2.5
Sep
-5.8
Oct
-2.1
Nov
+3.8
Dec
+1.3
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about West Pharmaceutical Services, Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
WST — recent news
Loading headlines…
Quality scorecard
vs Health Care · 31 peers · percentile rank
50 / 100
Average
ROIC15.0%
60
ROE15.5%
66
Gross margin35.9%
21
Operating margin20.7%
50
FCF yield1.9%
10
Net debt / EBITDAnet cash
93
Percentile vs 31 Health Care peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.